Alerts & Updates 16th Jul 2024

Strengthening of Export Regulations concerning Drugs in India

Authors

Sanjay Notani Partner | Mumbai
Suhail Nathani Managing Partner | Mumbai
Harika Bakaraju Principal Associate | Mumbai
Shweta Kushe Associate | Mumbai

Latest Thought Leadership

News & Media 26th Apr 2025

Dailyhunt’s parent VerSe’s group CFO resigns amid other exits in finance team

Read More
Alerts & Updates 25th Apr 2025

RBI’s Draft Directions on Securitisation of Stressed Assets, 2025 (Released on April 9, 2025)

Read More
Newsletter/Booklets 22nd Apr 2025

Competition Law & Policy Newsletter for Q1 of 2025

Read More
Alerts & Updates 22nd Apr 2025

Implementation of the Cape Town Convention in India: A Legal Framework for Protection and Enforcement of Security Interests in Aircraft

Read More

On July 3, 2024, the Central Drugs Standard Control Organisation (CDSCO) issued a guidance document outlining the new procedures for obtaining export NOCs, including stringent documentation requirements and quality control measures. This regulatory development comes in lieu of measures India has been undertaking to enhance drug safety and quality of its drug exports by centralizing the issuance of “No Objection Certificates” (NOCs) for exporting unapproved, banned, or new drugs. It aims to restore confidence in Indian pharmaceuticals by ensuring stringent regulatory oversight.

Read the detailed update here

Privacy Policy

As per the rules of the Bar Council of India, lawyers and law firms are not permitted to solicit work or advertise. By clicking on the "I Agree" button, you acknowledge and confirm that you are seeking information relating to Economic Laws Practice (ELP) of your own accord and there has been no advertisement, personal communication, solicitation, invitation or any other inducement of any sort whatsoever by or on behalf of ELP or any of its members to solicit any work through this website.